Profiel
Frank J.
Slack is the founder of Redona Therapeutics, Inc. founded in 2016.
Dr. Slack is also the founder of Impilo Therapeutics, Inc.,MiraDx, Inc. Dr. Slack is currently a Professor at Yale University.
Actieve functies van Frank Slack
| Bedrijven | Functie | Begin |
|---|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 05-07-2010 |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Oprichter | - |
Eerdere bekende functies van Frank Slack
| Bedrijven | Functie | Einde |
|---|---|---|
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Oprichter | - |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MiraDx, Inc.
MiraDx, Inc. Medical/Nursing ServicesHealth Services Provides research and testing for cancer treatments | Health Services |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics for cancer and autoimmune diseases | Health Technology |
Impilo Therapeutics, Inc.
Impilo Therapeutics, Inc. Packaged SoftwareTechnology Services Develops a platform for delivering nucleic acid-based medicines to solid tumor cancers | Technology Services |
















